<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33589735</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2045-2322</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Feb</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Scientific reports</Title>
          <ISOAbbreviation>Sci Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Purification and characterization of bacteriocins-like inhibitory substances from food isolated Enterococcus faecalis OS13 with activity against nosocomial enterococci.</ArticleTitle>
        <Pagination>
          <StartPage>3795</StartPage>
          <MedlinePgn>3795</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">3795</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-83357-z</ELocationID>
        <Abstract>
          <AbstractText>Nosocomial infections caused by enterococci are an ongoing global threat. Thus, finding therapeutic agents for the treatment of such infections are crucial. Some Enterococcus faecalis strains are able to produce antimicrobial peptides called bacteriocins. We analyzed 65 E. faecalis isolates from 43 food samples and 22 clinical samples in Egypt for 17 common bacteriocin-encoding genes of Enterococcus spp. These genes were absent in 11 isolates that showed antimicrobial activity putatively due to bacteriocins (three from food, including isolate OS13, and eight from clinical isolates). The food-isolated E. faecalis OS13 produced bacteriocin-like inhibitory substances (BLIS) named enterocin OS13, which comprised two peptides (enterocin OS13α OS13β) that inhibited the growth of antibiotic-resistant nosocomial E. faecalis and E. faecium isolates. The molecular weights of enterocin OS13α and OS13β were determined as 8079 Da and 7859 Da, respectively, and both were heat-labile. Enterocin OS13α was sensitive to proteinase K, while enterocin OS13β was resistant. Characterization of E. faecalis OS13 isolate revealed that it belonged to sequence type 116. It was non-hemolytic, bile salt hydrolase-negative, gelatinase-positive, and sensitive to ampicillin, penicillin, vancomycin, erythromycin, kanamycin, and gentamicin. In conclusion, BLIS as enterocin OS13α and OS13β represent antimicrobial agents with activities against antibiotic-resistant enterococcal isolates.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>El-Gendy</LastName>
            <ForeName>Ahmed O</ForeName>
            <Initials>AO</Initials>
            <AffiliationInfo>
              <Affiliation>Microbiology and Immunology Department, Faculty of Pharmacy, Beni-Suef University, Salah Salem Street, Beni Suef, 62511, Egypt. Ahmed.elgendy@pharm.bsu.edu.eg.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brede</LastName>
            <ForeName>Dag A</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Biotechnology and Food Science, Laboratory of Microbial Gene Technology and Food Microbiology, Norwegian University of Life Sciences, Ås, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Essam</LastName>
            <ForeName>Tamer M</ForeName>
            <Initials>TM</Initials>
            <AffiliationInfo>
              <Affiliation>Microbiology and Immunology Department and Biotechnology Centre, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Amin</LastName>
            <ForeName>Magdy A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Microbiology and Immunology Department and Biotechnology Centre, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ahmed</LastName>
            <ForeName>Shaban H</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Microbiology and Immunology Department, Faculty of Medicine, Assiut University, Asyût, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Holo</LastName>
            <ForeName>Helge</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Biotechnology and Food Science, Laboratory of Microbial Gene Technology and Food Microbiology, Norwegian University of Life Sciences, Ås, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nes</LastName>
            <ForeName>Ingolf F</ForeName>
            <Initials>IF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Biotechnology and Food Science, Laboratory of Microbial Gene Technology and Food Microbiology, Norwegian University of Life Sciences, Ås, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shamikh</LastName>
            <ForeName>Yara I</ForeName>
            <Initials>YI</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, Nahda University, Beni Suef, Egypt.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Virology, Egypt Center for Research and Regenerative Medicine, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>02</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Sci Rep</MedlineTA>
        <NlmUniqueID>101563288</NlmUniqueID>
        <ISSNLinking>2045-2322</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001430">Bacteriocins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001430" MajorTopicYN="N">Bacteriocins</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004534" MajorTopicYN="N" Type="Geographic">Egypt</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013293" MajorTopicYN="N">Enterococcus faecalis</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016984" MajorTopicYN="N">Enterococcus faecium</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005516" MajorTopicYN="N">Food Microbiology</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>7</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33589735</ArticleId>
        <ArticleId IdType="pmc">PMC7884432</ArticleId>
        <ArticleId IdType="doi">10.1038/s41598-021-83357-z</ArticleId>
        <ArticleId IdType="pii">10.1038/s41598-021-83357-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Chun W, Hancock RE. Action of lysozyme and nisin mixtures against lactic acid bacteria. Int. J. Food Microbiol. 2000;60:25–32. doi: 10.1016/s0168-1605(00)00330-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0168-1605(00)00330-5</ArticleId>
            <ArticleId IdType="pubmed">11014519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parada JL, Caron CR, Medeiros ABP, Soccol CR. Bacteriocins from lactic acid bacteria: Purification, properties and use as biopreservatives. Braz. Arch. Biol. Technol. 2007;50:512–542. doi: 10.1590/S1516-89132007000300018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1516-89132007000300018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sánchez J, et al.  Cloning and heterologous production of Hiracin JM79, a Sec-dependent bacteriocin produced by Enterococcus hirae DCH5, in lactic acid bacteria and Pichia pastoris. Appl. Environ. Microbiol. 2008;74:2471–2479. doi: 10.1128/aem.02559-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.02559-07</ArticleId>
            <ArticleId IdType="pmc">PMC2293139</ArticleId>
            <ArticleId IdType="pubmed">18310424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aakra A, Nyquist OL, Snipen L, Reiersen TS, Nes IF. Survey of genomic diversity among Enterococcus faecalis strains by microarray-based comparative genomic hybridization. Appl. Environ. Microbiol. 2007;73:2207–2217. doi: 10.1128/aem.01599-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.01599-06</ArticleId>
            <ArticleId IdType="pmc">PMC1855650</ArticleId>
            <ArticleId IdType="pubmed">17220255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baldassarri L, Creti R, Montanaro L, Orefici G, Arciola CR. Pathogenesis of implant infections by enterococci. Int. J. Artif. Organs. 2005;28:1101–1109. doi: 10.1177/039139880502801107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/039139880502801107</ArticleId>
            <ArticleId IdType="pubmed">16353116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coates AR, Hu Y. Novel approaches to developing new antibiotics for bacterial infections. Br. J. Pharmacol. 2007;152:1147–1154. doi: 10.1038/sj.bjp.0707432.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjp.0707432</ArticleId>
            <ArticleId IdType="pmc">PMC2189988</ArticleId>
            <ArticleId IdType="pubmed">17704820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kristich, C. J., Rice, L. B. &amp; Arias, C. A. In Enterococci: From Commensals to Leading Causes of Drug Resistant Infection (eds Gilmore, M. S. et al.) (Massachusetts Eye and Ear Infirmary, 2014).</Citation>
        </Reference>
        <Reference>
          <Citation>Sánchez J, et al.  Antimicrobial and safety aspects, and biotechnological potential of bacteriocinogenic enterococci isolated from mallard ducks (Anas platyrhynchos) Int. J. Food Microbiol. 2007;117:295–305. doi: 10.1016/j.ijfoodmicro.2007.04.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijfoodmicro.2007.04.012</ArticleId>
            <ArticleId IdType="pubmed">17543406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilsen T, Nes IF, Holo H. Enterolysin A, a cell wall-degrading bacteriocin from Enterococcus faecalis LMG 2333. App. Environ. Microbiol. 2003;69:2975–2984. doi: 10.1128/aem.69.5.2975-2984.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.69.5.2975-2984.2003</ArticleId>
            <ArticleId IdType="pmc">PMC154489</ArticleId>
            <ArticleId IdType="pubmed">12732574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franz CM, van Belkum MJ, Holzapfel WH, Abriouel H, Gálvez A. Diversity of enterococcal bacteriocins and their grouping in a new classification scheme. FEMS Microbiol. Rev. 2007;31:293–310. doi: 10.1111/j.1574-6976.2007.00064.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6976.2007.00064.x</ArticleId>
            <ArticleId IdType="pubmed">17298586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acedo JZ, Chiorean S, Vederas JC, van Belkum MJ. The expanding structural variety among bacteriocins from Gram-positive bacteria. FEMS Microbiol. Rev. 2018;42:805–828. doi: 10.1093/femsre/fuy033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/femsre/fuy033</ArticleId>
            <ArticleId IdType="pubmed">30085042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nes IF, Diep DB, Holo H. Bacteriocin diversity in Streptococcus and Enterococcus. J. Bacteriol. 2007;189:1189–1198. doi: 10.1128/jb.01254-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jb.01254-06</ArticleId>
            <ArticleId IdType="pmc">PMC1797368</ArticleId>
            <ArticleId IdType="pubmed">17098898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cotter PD, Hill C, Ross RP. Bacteriocins: Developing innate immunity for food. Nat. Rev. Microbiol. 2005;3:777–788. doi: 10.1038/nrmicro1273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro1273</ArticleId>
            <ArticleId IdType="pubmed">16205711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cleveland J, Montville TJ, Nes IF, Chikindas ML. Bacteriocins: Safe, natural antimicrobials for food preservation. Int. J. Food Microbiol. 2001;71:1–20. doi: 10.1016/s0168-1605(01)00560-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0168-1605(01)00560-8</ArticleId>
            <ArticleId IdType="pubmed">11764886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papagianni M. Ribosomally synthesized peptides with antimicrobial properties: Biosynthesis, structure, function, and applications. Biotechnol. Adv. 2003;21:465–499. doi: 10.1016/s0734-9750(03)00077-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0734-9750(03)00077-6</ArticleId>
            <ArticleId IdType="pubmed">14499150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Martinis EC, Públio MR, Santarosa PR, Freitas FZ. Antilisterial activity of lactic acid bacteria isolated from vacuum-packaged Brazilian meat and meat products. Braz. J. Microbiol. 2001;32:32–37. doi: 10.1590/S1517-83822001000100008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1517-83822001000100008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giuliani A, Pirri G, Nicoletto S. Antimicrobial peptides: An overview of a promising class of therapeutics. Open Life Sci. 2007;2:1–33. doi: 10.2478/s11535-007-0010-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2478/s11535-007-0010-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huys G, et al.  Microbial characterization of probiotics–advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC) Mol. Nutr. Food Res. 2013;57:1479–1504. doi: 10.1002/mnfr.201300065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mnfr.201300065</ArticleId>
            <ArticleId IdType="pmc">PMC3910143</ArticleId>
            <ArticleId IdType="pubmed">23801655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franz CM, Huch M, Abriouel H, Holzapfel W, Gálvez A. Enterococci as probiotics and their implications in food safety. Int. J. Food Microbiol. 2011;151:125–140. doi: 10.1016/j.ijfoodmicro.2011.08.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijfoodmicro.2011.08.014</ArticleId>
            <ArticleId IdType="pubmed">21962867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nissen-Meyer J, Oppegård C, Rogne P, Haugen HS, Kristiansen PE. Structure and mode-of-action of the two-peptide (class-IIb) bacteriocins. Probiotics Antimicrob. Proteins. 2010;2:52–60. doi: 10.1007/s12602-009-9021-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12602-009-9021-z</ArticleId>
            <ArticleId IdType="pmc">PMC2850506</ArticleId>
            <ArticleId IdType="pubmed">20383320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riley MA. Molecular mechanisms of bacteriocin evolution. Annu. Rev. Genet. 1998;32:255–278. doi: 10.1146/annurev.genet.32.1.255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.genet.32.1.255</ArticleId>
            <ArticleId IdType="pubmed">9928481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med. 2016;8:39. doi: 10.1186/s13073-016-0294-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-016-0294-z</ArticleId>
            <ArticleId IdType="pmc">PMC4831151</ArticleId>
            <ArticleId IdType="pubmed">27074706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulfer A, Blaser MJ. Risks of antibiotic exposures early in life on the developing microbiome. PLoS Pathog. 2015;11:e1004903. doi: 10.1371/journal.ppat.1004903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1004903</ArticleId>
            <ArticleId IdType="pmc">PMC4489621</ArticleId>
            <ArticleId IdType="pubmed">26135581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birri DJ, Brede DA, Nes IF. Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant. Appl. Environ. Microbiol. 2012;78:402–410. doi: 10.1128/aem.06588-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.06588-11</ArticleId>
            <ArticleId IdType="pmc">PMC3255740</ArticleId>
            <ArticleId IdType="pubmed">22101034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sambrook, H. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor, 1989).</Citation>
        </Reference>
        <Reference>
          <Citation>Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007;24:1596–1599. doi: 10.1093/molbev/msm092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/molbev/msm092</ArticleId>
            <ArticleId IdType="pubmed">17488738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Vuyst L, Callewaert R, Pot B. Characterization of the antagonistic activity of Lactobacillus amylovorus DCE 471 and large scale isolation of its bacteriocin amylovorin L471. Syst. Appl. Microbiol. 1996;19:9–20. doi: 10.1016/S0723-2020(96)80003-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0723-2020(96)80003-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holo H, Nilssen O, Nes IF. Lactococcin A, a new bacteriocin from Lactococcus lactis subsp. cremoris: Isolation and characterization of the protein and its gene. J. Bacteriol. 1991;173:3879–3887. doi: 10.1128/jb.173.12.3879-3887.1991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jb.173.12.3879-3887.1991</ArticleId>
            <ArticleId IdType="pmc">PMC208020</ArticleId>
            <ArticleId IdType="pubmed">1904860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen YS, et al.  Leucocin C-607, a novel bacteriocin from the multiple-bacteriocin-producing Leuconostoc pseudomesenteroides 607 Isolated from Persimmon. Probiotics Antimicrob. Proteins. 2018;10:148–156. doi: 10.1007/s12602-017-9359-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12602-017-9359-6</ArticleId>
            <ArticleId IdType="pubmed">29177756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clinical &amp; Institute, L. S. Vol. 32 (Clinical and Laboratory Standards Institute Wayne, PA, 2012).</Citation>
        </Reference>
        <Reference>
          <Citation>Ruiz-Garbajosa P, et al.  Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J. Clin. Microbiol. 2006;44:2220–2228. doi: 10.1128/jcm.02596-05.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jcm.02596-05</ArticleId>
            <ArticleId IdType="pmc">PMC1489431</ArticleId>
            <ArticleId IdType="pubmed">16757624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. eBURST: Inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 2004;186:1518–1530. doi: 10.1128/jb.186.5.1518-1530.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jb.186.5.1518-1530.2004</ArticleId>
            <ArticleId IdType="pmc">PMC344416</ArticleId>
            <ArticleId IdType="pubmed">14973027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dündar H, Atakay M, Çelikbıçak Ö, Salih B, Bozoğlu F. Comparison of two methods for purification of enterocin B, a bacteriocin produced by Enterococcus faecium W3. Prep. Biochem. Biotechnol. 2015;45:796–809. doi: 10.1080/10826068.2014.958165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/10826068.2014.958165</ArticleId>
            <ArticleId IdType="pubmed">25181442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birri DJ, Brede DA, Forberg T, Holo H, Nes IF. Molecular and genetic characterization of a novel bacteriocin locus in Enterococcus avium isolates from infants. Appl. Environ. Microbiol. 2010;76:483–492. doi: 10.1128/aem.01597-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.01597-09</ArticleId>
            <ArticleId IdType="pmc">PMC2805230</ArticleId>
            <ArticleId IdType="pubmed">19933345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehmeti I, et al.  Transcriptome, proteome, and metabolite analyses of a lactate dehydrogenase-negative mutant of Enterococcus faecalis V583. Appl. Environ. Microbiol. 2011;77:2406–2413. doi: 10.1128/aem.02485-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.02485-10</ArticleId>
            <ArticleId IdType="pmc">PMC3067458</ArticleId>
            <ArticleId IdType="pubmed">21296946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SY, et al.  Purification and molecular cloning of cDNA for an inducible antibacterial protein of larvae of a coleopteran insect, Holotrichia diomphalia. J. Biochem. 1994;115:82–86. doi: 10.1093/oxfordjournals.jbchem.a124309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.jbchem.a124309</ArticleId>
            <ArticleId IdType="pubmed">8188641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farías ME, Farías RN, de Ruiz Holgado AP, Sesma F. Purification and N-terminal amino acid sequence of Enterocin CRL 35, a 'pediocin-like' bacteriocin produced by Enterococcus faecium CRL 35. Lett. Appl. Microbiol. 1996;22:417–419. doi: 10.1111/j.1472-765x.1996.tb01193.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1472-765x.1996.tb01193.x</ArticleId>
            <ArticleId IdType="pubmed">8695065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Gendy A, Essam T, Amin M, Ahmed S, Nes I. Clinical screening for bacteriocinogenic Enterococcus faecalis isolated from intensive care unit inpatient in Egypt. J. Microb. Biochem. Technol. 2013;4:161–167.</Citation>
        </Reference>
        <Reference>
          <Citation>Nes IF, Holo H. Class II antimicrobial peptides from lactic acid bacteria. Biopolymers. 2000;55:50–61. doi: 10.1002/1097-0282(2000)55:1&lt;50::aid-bip50&gt;3.0.co;2-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1097-0282(2000)55:1&lt;50::aid-bip50&gt;3.0.co;2-3</ArticleId>
            <ArticleId IdType="pubmed">10931441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson AP, Uttley AH, Woodford N, George RC. Resistance to vancomycin and teicoplanin: An emerging clinical problem. Clin. Microbiol. Rev. 1990;3:280–291. doi: 10.1128/cmr.3.3.280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/cmr.3.3.280</ArticleId>
            <ArticleId IdType="pmc">PMC358160</ArticleId>
            <ArticleId IdType="pubmed">2143434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Line JE, et al.  Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 2008;52:1094–1100. doi: 10.1128/aac.01569-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aac.01569-06</ArticleId>
            <ArticleId IdType="pmc">PMC2258513</ArticleId>
            <ArticleId IdType="pubmed">18086839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Svetoch EA, et al.  Diverse antimicrobial killing by Enterococcus faecium E 50–52 bacteriocin. J. Agric. Food Chem. 2008;56:1942–1948. doi: 10.1021/jf073284g.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf073284g</ArticleId>
            <ArticleId IdType="pubmed">18293921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Messaoudi S, et al.  Purification and characterization of a new bacteriocin active against Campylobacter produced by Lactobacillus salivarius SMXD51. Food Microbiol. 2012;32:129–134. doi: 10.1016/j.fm.2012.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fm.2012.05.002</ArticleId>
            <ArticleId IdType="pubmed">22850384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sahm DF, et al.  In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 1989;33:1588–1591. doi: 10.1128/aac.33.9.1588.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aac.33.9.1588</ArticleId>
            <ArticleId IdType="pmc">PMC172707</ArticleId>
            <ArticleId IdType="pubmed">2554802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arias CA, Murray BE. The rise of the Enterococcus: Beyond vancomycin resistance. Nat. Rev. Microbiol. 2012;10:266–278. doi: 10.1038/nrmicro2761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro2761</ArticleId>
            <ArticleId IdType="pmc">PMC3621121</ArticleId>
            <ArticleId IdType="pubmed">22421879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barber KE, King ST, Stover KR, Pogue JM. Therapeutic options for vancomycin-resistant enterococcal bacteremia. Expert Rev. Anti-infect. Ther. 2015;13:363–377. doi: 10.1586/14787210.2015.1001839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14787210.2015.1001839</ArticleId>
            <ArticleId IdType="pubmed">25661903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mutters NT, Werner G, Tacconelli E, Mischnik A. Treatment options for serious infections caused by vancomycin-resistant enterococci. Dtsch. Med. Wochenschr. 2015;1946(140):42–45. doi: 10.1055/s-0040-100428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0040-100428</ArticleId>
            <ArticleId IdType="pubmed">25580973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holo H, Jeknic Z, Daeschel M, Stevanovic S, Nes IF. Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics. Microbiology. 2001;147:643–651. doi: 10.1099/00221287-147-3-643.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/00221287-147-3-643</ArticleId>
            <ArticleId IdType="pubmed">11238971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maldonado A, Ruiz-Barba JL, Jiménez-Díaz R. Purification and genetic characterization of plantaricin NC8, a novel coculture-inducible two-peptide bacteriocin from Lactobacillus plantarum NC8. Appl. Environ. Microbiol. 2003;69:383–389. doi: 10.1128/aem.69.1.383-389.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.69.1.383-389.2003</ArticleId>
            <ArticleId IdType="pmc">PMC152457</ArticleId>
            <ArticleId IdType="pubmed">12514019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morgan SM, O’Connor PM, Cotter PD, Ross RP, Hill C. Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob. Agents Chemother. 2005;49:2606–2611. doi: 10.1128/aac.49.7.2606-2611.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aac.49.7.2606-2611.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1168663</ArticleId>
            <ArticleId IdType="pubmed">15980326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamazaki K, Suzuki M, Kawai Y, Inoue N, Montville TJ. Purification and characterization of a novel class IIa bacteriocin, piscicocin CS526, from surimi-associated Carnobacterium piscicola CS526. Appl. Environ. Microbiol. 2005;71:554–557. doi: 10.1128/aem.71.1.554-557.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.71.1.554-557.2005</ArticleId>
            <ArticleId IdType="pmc">PMC544203</ArticleId>
            <ArticleId IdType="pubmed">15640235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mareková M, Lauková A, Skaugen M, Nes I. Isolation and characterization of a new bacteriocin, termed enterocin M, produced by environmental isolate Enterococcus faecium AL41. J. Ind. Microbiol. Biotechnol. 2007;34:533–537. doi: 10.1007/s10295-007-0226-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10295-007-0226-4</ArticleId>
            <ArticleId IdType="pubmed">17551760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aymerich T, et al.  Biochemical and genetic characterization of enterocin A from Enterococcus faecium, a new antilisterial bacteriocin in the pediocin family of bacteriocins. Appl. Environ. Microbiol. 1996;62:1676–1682. doi: 10.1128/aem.62.5.1676-1682.1996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.62.5.1676-1682.1996</ArticleId>
            <ArticleId IdType="pmc">PMC167941</ArticleId>
            <ArticleId IdType="pubmed">8633865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cintas LM, et al.  Isolation and characterization of pediocin L50, a new bacteriocin from Pediococcus acidilactici with a broad inhibitory spectrum. Appl. Environ. Microbiol. 1995;61:2643–2648. doi: 10.1128/aem.61.7.2643-2648.1995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.61.7.2643-2648.1995</ArticleId>
            <ArticleId IdType="pmc">PMC167537</ArticleId>
            <ArticleId IdType="pubmed">7618877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barefoot SF, Klaenhammer TR. Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl. Environ. Microbiol. 1983;45:1808–1815. doi: 10.1128/aem.45.6.1808-1815.1983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.45.6.1808-1815.1983</ArticleId>
            <ArticleId IdType="pmc">PMC242543</ArticleId>
            <ArticleId IdType="pubmed">6410990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stoffels G, et al.  Purification and characterization of a new bacteriocin isolated from a Carnobacterium sp. Appl. Environ. Microbiol. 1992;58:1417–1422. doi: 10.1128/aem.58.5.1417-1422.1992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.58.5.1417-1422.1992</ArticleId>
            <ArticleId IdType="pmc">PMC195619</ArticleId>
            <ArticleId IdType="pubmed">1622206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hassan MU, et al.  Characterisation of bacteriocins produced by Lactobacillus spp. isolated from the traditional Pakistani yoghurt and their antimicrobial activity against common foodborne pathogens. Biomed. Res. Int. 2020;2020:8281623. doi: 10.1155/2020/8281623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2020/8281623</ArticleId>
            <ArticleId IdType="pmc">PMC7503110</ArticleId>
            <ArticleId IdType="pubmed">33005689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martínez B, Suárez JE, Rodríguez A. Lactococcin 972: A homodimeric lactococcal bacteriocin whose primary target is not the plasma membrane. Microbiology. 1996;142(Pt 9):2393–2398. doi: 10.1099/00221287-142-9-2393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/00221287-142-9-2393</ArticleId>
            <ArticleId IdType="pubmed">21818877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tiwari SK, Srivastava S. Purification and characterization of plantaricin LR14: A novel bacteriocin produced by Lactobacillus plantarum LR/14. Appl. Microbiol. Biotechnol. 2008;79:759–767. doi: 10.1007/s00253-008-1482-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00253-008-1482-6</ArticleId>
            <ArticleId IdType="pubmed">18496687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borrero J, et al.  Characterization of garvicin ML, a novel circular bacteriocin produced by Lactococcus garvieae DCC43, isolated from mallard ducks (Anas platyrhynchos) Appl. Environ. Microbiol. 2011;77:369–373. doi: 10.1128/aem.01173-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.01173-10</ArticleId>
            <ArticleId IdType="pmc">PMC3019728</ArticleId>
            <ArticleId IdType="pubmed">21057028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kemperman R, et al.  Identification and characterization of two novel clostridial bacteriocins, circularin A and closticin 574. Appl. Environ. Microbiol. 2003;69:1589–1597. doi: 10.1128/aem.69.3.1589-1597.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.69.3.1589-1597.2003</ArticleId>
            <ArticleId IdType="pmc">PMC150056</ArticleId>
            <ArticleId IdType="pubmed">12620847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Busani L, et al.  Antimicrobial susceptibility of vancomycin-susceptible and -resistant enterococci isolated in Italy from raw meat products, farm animals, and human infections. Int. J. Food Microbiol. 2004;97:17–22. doi: 10.1016/j.ijfoodmicro.2004.04.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijfoodmicro.2004.04.008</ArticleId>
            <ArticleId IdType="pubmed">15527914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lepage E, et al.  Comparative genomic hybridization analysis of Enterococcus faecalis: Identification of genes absent from food strains. J. Bacteriol. 2006;188:6858–6868. doi: 10.1128/jb.00421-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jb.00421-06</ArticleId>
            <ArticleId IdType="pmc">PMC1595521</ArticleId>
            <ArticleId IdType="pubmed">16980489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koch S, Hufnagel M, Theilacker C, Huebner J. Enterococcal infections: Host response, therapeutic, and prophylactic possibilities. Vaccine. 2004;22:822–830. doi: 10.1016/j.vaccine.2003.11.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2003.11.027</ArticleId>
            <ArticleId IdType="pubmed">15040934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semedo T, et al.  Virulence factors in food, clinical and reference Enterococci: A common trait in the genus? Syst. Appl. Microbiol. 2003;26:13–22. doi: 10.1078/072320203322337263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1078/072320203322337263</ArticleId>
            <ArticleId IdType="pubmed">12747405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shankar N, Baghdayan AS, Gilmore MS. Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. Nature. 2002;417:746–750. doi: 10.1038/nature00802.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature00802</ArticleId>
            <ArticleId IdType="pubmed">12066186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Begley M, Hill C, Gahan CG. Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 2006;72:1729–1738. doi: 10.1128/aem.72.3.1729-1738.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aem.72.3.1729-1738.2006</ArticleId>
            <ArticleId IdType="pmc">PMC1393245</ArticleId>
            <ArticleId IdType="pubmed">16517616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohamed JA, Huang DB. Biofilm formation by enterococci. J. Med. Microbiol. 2007;56:1581–1588. doi: 10.1099/jmm.0.47331-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.47331-0</ArticleId>
            <ArticleId IdType="pubmed">18033823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franz CM, Stiles ME, Schleifer KH, Holzapfel WH. Enterococci in foods—A conundrum for food safety. Int. J. Food Microbiol. 2003;88:105–122. doi: 10.1016/s0168-1605(03)00174-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0168-1605(03)00174-0</ArticleId>
            <ArticleId IdType="pubmed">14596984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klein G. Taxonomy, ecology and antibiotic resistance of enterococci from food and the gastro-intestinal tract. Int. J. Food Microbiol. 2003;88:123–131. doi: 10.1016/s0168-1605(03)00175-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0168-1605(03)00175-2</ArticleId>
            <ArticleId IdType="pubmed">14596985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choho G, et al.  Characterization of a bacteriocin-producing strain of Enterococcus faecalis from cow’s milk used in the production of Moroccan traditional dairy foods. World J. Microbiol. Biotechnol. 2008;24:997–1001. doi: 10.1007/s11274-007-9567-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11274-007-9567-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hickey RM, Twomey DP, Ross RP, Hill C. Production of enterolysin A by a raw milk enterococcal isolate exhibiting multiple virulence factors. Microbiology. 2003;149:655–664. doi: 10.1099/mic.0.25949-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.25949-0</ArticleId>
            <ArticleId IdType="pubmed">12634334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McBride SM, et al.  Genetic variation and evolution of the pathogenicity island of Enterococcus faecalis. J. Bacteriol. 2009;191:3392–3402. doi: 10.1128/jb.00031-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jb.00031-09</ArticleId>
            <ArticleId IdType="pmc">PMC2687173</ArticleId>
            <ArticleId IdType="pubmed">19270086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agersø Y, et al.  Vancomycin-resistant Enterococcus faecalis isolates from a Danish patient and two healthy human volunteers are possibly related to isolates from imported turkey meat. J. Antimicrob. Chemother. 2008;62:844–845. doi: 10.1093/jac/dkn271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkn271</ArticleId>
            <ArticleId IdType="pubmed">18586660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quiñones D, Kobayashi N, Nagashima S. Molecular epidemiologic analysis of Enterococcus faecalis isolates in Cuba by multilocus sequence typing. Microb. Drug Resist. 2009;15:287–293. doi: 10.1089/mdr.2009.0028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/mdr.2009.0028</ArticleId>
            <ArticleId IdType="pmc">PMC3145955</ArticleId>
            <ArticleId IdType="pubmed">19857135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawalec M, et al.  Clonal structure of Enterococcus faecalis isolated from Polish hospitals: Characterization of epidemic clones. J. Clin. Microbiol. 2007;45:147–153. doi: 10.1128/jcm.01704-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jcm.01704-06</ArticleId>
            <ArticleId IdType="pmc">PMC1828945</ArticleId>
            <ArticleId IdType="pubmed">17093020</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
